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Abstract
Toxoplasma gondii is a wide spread pathogen that can cause severe and even fatal disease in fetuses and immune-
compromised hosts. As an obligate intracellular parasite, Toxoplasma must alter the environment of its host cell in order to
establish its replicative niche. This is accomplished, in part, by secretion of factors into the host cell that act to modulate
processes such as transcription. Previous studies demonstrated that genes encoding transcription factors such as c-jun,
junB, EGR1, and EGR2 were amongst the host genes that were the most rapidly upregulated following infection. In cells
stimulated with growth factors, these genes are regulated by a transcription factor named Serum Response Factor. Serum
Response Factor is a ubiquitously expressed DNA binding protein that regulates growth and actin cytoskeleton genes via
MAP kinase or actin cytoskeletal signaling, respectively. Here, we report that Toxoplasma infection leads to the rapid
activation of Serum Response Factor. Serum Response Factor activation is a Toxoplasma-specific event since the
transcription factor is not activated by the closely related protozoan parasite, Neospora caninum. We further demonstrate
that Serum Response Factor activation requires a parasite-derived secreted factor that signals via host MAP kinases but
independently of the host actin cytoskeleton. Together, these data define Serum Response Factor as a host cell transcription
factor that regulates immediate early gene expression in Toxoplasma-infected cells.
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Introduction
Toxoplasma gondii is an obligate intracellular protozoan parasite
that is an important pathogen of fetuses and immune-compro-
mised patients [1,2]. The tissue damage seen in these individuals is
the direct result of the parasite’s lytic growth cycle that is
composed of repeated rounds of host cell invasion, replication, and
egress [3]. Toxoplasma’s ability to complete each round of this cycle
is dependent on the parasite modulating its host cell. Host cell
pathways/processes targeted by the parasite include the microtu-
bule cytoskeleton [4,5,6], organelle localization [7], apoptosis
[8,9], and transcription [10,11,12]. In most cases, the parasite
factors that direct these changes as well their targets within the
host cell are unknown.
We and others have used transcriptional profiling assays as an
approach to identify host cell pathways important for Toxoplasma
growth [10,11,12]. These studies demonstrated that infection leads
to upregulation of genes at both early (within 2 hpi) and late time
points following infection. While many of the early genes encode
proteins involved in host immune responses, others including c-
jun, junB, c-myc, EGR1, and EGR2 were also upregulated. These
genes, which are well known immediate early response genes in
growth factor-stimulated cells, encode transcription factors that
regulate cell survival and growth genes [13,14]. The rapid
responsiveness of these genes to growth factor stimulation is due
to serum response elements (SREs) in the promoters of these genes
[15].
SREs are bipartite DNA-binding sites consisting of a binding
site for Serum Response Factor (SRF) and an adjacent site for the
Ternary Complex Factors (TCFs), which are a family of ets-
domain containing transcription factors of which ELK1 and
SAP1a are the two best described [16,17]. Growth factor signaling
activates SRF/TCF by virtue of Mitogen Activated Protein (MAP)
kinase phosphorylation of TCF proteins [18]. SRF can also bind to
a distinct promoter element found in many genes that encode actin
cytoskeleton associated proteins [19]. To regulate these genes,
SRF interacts with MAL and other myocardin/MKL family
members [20]. These proteins are normally bound to g-actin,
which prevents them from interacting with SRF. But changes in g-
actin levels release MAL that allows MAL to interact with SRF
and modulate gene expression [21].
The goal of this study was to determine whether parasite
activation of host immediate early genes was due to Toxoplasma
signaling through SRF. Here we report that Toxoplasma activates
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18335SRF through MAPK signaling. SRF activation is dependent on
release of a parasite-derived secreted factor that is likely Toxoplasma
specific since SRF was not activated by the closely related parasite
Neospora caninum.
Materials and Methods
Cells and Parasites
Human foreskin fibroblasts (HFFs), HeLa cells, and murine
embryonic fibroblasts (MEFs) were grown in DMEM containing
10% heat-inactivated fetal bovine serum (FBS), L-glutamine, and
penicillin/streptomycin as previously described [22]. COS cells
stably transfected with SRE-CD8 were grown in the same media
supplemented with G418 and were kindly provided by Dr.
Richard Treisman (London Research Institute) [21]. SB203580,
U0126, and SP600125 were from Calbiochem (San Diego, CA).
Cytochalasin D, 4-bromophenacyl bromide and Epidermal
Growth Factor (EGF) were purchased from Sigma (St. Louis,
MO). Recombinant full length lethal factor, lethal factor-TcdB
fusion, and protective antigen were purified from E. coli as
previously described [23] and were provided by Dr. Jimmy Ballard
(Univ. of Oklahoma Health Sciences Center).
The RH (Type I), GT1 (Type I), Pru (Type II), CTG (Type III)
Toxoplasma and Neospora caninum NC-1 (from Dr. Dan Howe; Univ.
of Kentucky) strains were grown in HFFs [10]. RH stably
expressing both b-galactosidase and GFP were provided by Dr.
Gustavo Arrizabalaga (Univ. of Idaho) [4]. All parasites and host
cells were routinely tested for Mycoplasma contamination using the
MycoAlert Mycoplasma Detection Assay kit from Lonza (Basal,
Switzerland) and found to be negative. Unless otherwise stated,
experiments were performed at an apparent multiplicity of
infection (MOI) of 10:1 (parasites:host cells) and parasite numbers
were determined by counting with a hemocytometer. Parasites
were prepared by passage through a 27-gauge needle twice to lyse
host cells and then were extensively washed. Heat-killed parasites
were prepared by incubating purified parasites at 50uC for
20 minutes.
Luciferase Assays
MEFs were transfected and luciferase activity measured as
previously described [24]. The SRE-luc plasmid was purchased
from Stratagene (La Jolla, CA), pEGR4x-Luc was previously
described [24], SM22a-luc plasmid was provided by Dr. James
Tomasek (Univ. of Oklahoma Health Sciences Center) and
dominant negative p38 MAPK was from Dr. Roger Davis (Univ.
of Massachusetts). All cells were co-transfected with the pTK-Rel
(Promega; Madison, WI) to normalize transfection efficiencies.
Pharmacological inhibitors were added to host cells at the
indicated concentrations 309 before infection. Serum stimulation
was achieved by incubating cells overnight in media containing
0.1% heat-inactivated FBS and then adding fresh media
containing 15% FBS.
siRNA Transfections
Fifty ml of a 100 nM solution containing equimolar amounts of
3 different siRNAs against SRF (Ambion; Austin TX, Catalog #’s
4593, 142734, and 142734) was added to 1 ml of Lipofectamine
2000 (Invitrogen) diluted to 50 ml of Optimem (Invitrogen) in each
well of a 24-well plate. After 209 at room temperature, 2*10
5 HeLa
cells in 400 ml of antibiotic-free DMEM were added to each well.
The plates were incubated at 37uC for 24 h, rinsed 3 times with
DMEM, and incubated for a further 24 h in 1 ml of complete
media. Ambion’s Negative Control siRNA, which has no
homology to any known human gene, was used as a control.
Real Time PCR
Real-time PCR (RT-PCR) assays were performed essentially as
described [24]. Briefly total RNA was isolated using the Absolutely
RNA Microprep Kit (Stratagene) and treated with RNase-free
DNase (Ambion) to remove contaminating DNA. Total RNA was
reverse transcribed into cDNA using random primers and
Superscript III Reverse Transcriptase (Invitrogen). cDNAs were
diluted 1:10 and mixed with Power SYBR-Green PCR master mix
(Applied Biosystems, Foster City, CA), and PCR reaction
performed using an ABI 7500 Fast real-time PCR machine
(Applied Biosystems). Primers to detect EGR1 and EGR2 were
previously described [24]. The real time PCR primers used to
detect SRF were: 59ATCCCTGTTTCAGCAGTTCAGCTC39
and 59ATCATTCACTCTTGGTGCTGTGGG39. Because ß-
actin is a SRF target gene and because GAPDH is upregulated in
Toxoplasma-infected cells [24], RT-PCR data were normalized
using primers (59GGCAGCAGCCAAAGACAAGTATCA39 and
59TCATTTAAGCTGTCTGCCATGCGG39) to detect the HIF-
1a prolyl hydroxylase enzyme 1 (PHD1), which we demonstrated
is not upregulated by infection ([22] and data not shown). The
efficiency of the PCR primers was determined to be between 80
and 120% of the theoretical exponential amplification from cDNA
dilutions. The absence of genomic DNA contamination was
verified by the lack of PCR products when RNA was used as the
template for the PCR reactions. Experiments were performed in
triplicate, and each experiment was repeated at least three
independent times. Relative expression levels were determined as
described [24].
Bacterial Toxin Preparations
Recombinant full length lethal factor (LF), LF-TcdB fusion, and
protective antigen (PA) were purified from E. coli as previously
described [23,25]. The LF or LF-TcdB were added in equimolar
amounts with protective antigen as previously described [24]. LF
activity was assessed by examining MEK2 cleavage by Western
blotting lysates from cells treated with increasing concentrations of
toxin cell lysates with antibodies against MEK2 (from Cell
Signaling; Danvers, MA) and ß-actin (Ambion; Austin, TX). LF-
TcdB activity was assessed by immunofluorescence staining with
Alexa Fluor 568-conjugated phalloidin (Invitrogen; Carlsbad, CA)
to detect f-actin as described [4].
Flow Cytometry
COS cells stably expressing SRE-CD8 were mock-treated,
treated with 1 mM cytochalasin D, or infected with RH-GFP
parasites at a MOI of 1:2 (parasites:host cells). Cells were harvested
by scraping 24 h later and stained with APC-conjugated mouse
anti-human CD8 (clone OKT8) or mouse IgG2a as an isotype
control (EBioscience; San Diego, CA).
Results
Toxoplasma Infection Specifically Activates SRF
We previously showed that Toxoplasma rapidly activates the host
cell transcription factors EGR and AP-1 via upregulation of their
mRNAs [24]. Because SRF is an important regulator of EGR and
AP-1 transcription in growth-factor stimulated cells, experiments
were undertaken to test whether Toxoplasma uses SRF to activate
AP-1 and EGR. Thus, MEFs were transfected with a SRE-luc
reporter in which the luciferase gene is cloned downstream of
three SRF-regulated SREs. The transfected cells were then either
mock-infected or infected with increasing numbers of parasites.
After 4, 8, and 16 h, cells were lysed and luciferase activity was
measured. The data indicated that SRE-luc activity increased in a
Toxoplasma Regulates Serum Response Factor
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increases in luciferase activity could be detected within 4 h.
Incubation of heat-killed parasites (at a MOI of 10) with SRE-luc-
transfected cells did not upregulate luciferase activity after 18 h
indicating that SRF activation was not due to endotoxin (Fig. 1A).
Some changes in host gene expression in Toxoplasma-infected cells
can be the result of polymorphic factors that are secreted into the
host cell [12]. To determine whether SRF activation is also
polymorphic, we compared SRE-luc activation in cells infected with
either RH (a common laboratory type I strain) to cells infected with
GT1 (Type I), Pru (Type II), or CTG (type III) strains. The cells
were lysed 24 h later and luciferase activity was measured. The data
indicated that SRE-luc activity was increased in cells infected with
all four strains. We did note that the reporter was significantly more
stronglyupregulatedbyRHthanbyGT1,Pru,orCTG(Figure 1B).
We also compared SRF activity by the different Toxoplasma strains
by measuring increases in mRNA abundance of the SRF-target
gene EGR2 [24]. The data indicated that similar to the SRE-luc
results RH upregulated EGR2 more strongly than the other three
strains (Figure 1C). Similar results were observed when we
measured luciferase activity in Toxoplasma-infected cells transfected
with an EGR luciferase reporter (Figure 1D).
To address the possibility that SRF activation was a general
response of a host cell to infection, we tested whether Neospora
caninum, which is a closely related apicomplexan parasite, also
activated SRE-luc activity. In contrast to Toxoplasma-infected cells,
SRE-luc activity remained unchanged in Neospora-infected cells
(Fig. 1B). Together these data indicate that SRF activation is a
specific response of a host cell to Toxoplasma and that the parasite
factor that triggers SRF is most likely not polymorphic between the
three major Toxoplasma strain types.
SRF is Important for Immediate Early Host Gene
Expression in Toxoplasma-Infected Host Cells
A potential role for SRF in regulating immediate early host gene
expression in Toxoplasma-infected cells was examined by blocking
SRF expression using gene-specific siRNAs. Relative to negative
control siRNAs, SRF mRNA abundance was decreased by over
80% 48 h after cells were transfected with siRNAs against SRF
and this decrease lasted for at least 96 h (Figure 2A). To examine
Figure 1. Toxoplasma Activates SRF. A). SRE-luc transfected MEFs were infected with increasing numbers of parasites for the indicated times and
luciferase activity measured. Heat-killed parasites were added at a MOI of 10:1 (parasites:host cells). B). SRE-luc transfected MEFs were infected with
the indicated parasites at a MOI of 10. Lysates were collected at the indicated times and luciferase activity measured. C). Cells were mock-infected or
infected with equal numbers of RH and GT1 (Types I), Pru (Type II), and CTG (Type III) strains of Toxoplasma for indicated times before RNA was
harvested. Real-time PCR was used to measure EGR2 transcript abundance. D). pEGR4x-Luc transfected cells were infected with each parasite strain
and then luciferase activity was measured 16 h later. The dotted lines in all of the plots represent a 2-fold increase, which is considered the minimum
increase level to be considered significant. Shown are averages and standard deviations of three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0018335.g001
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infected cells, EGR1 and EGR2 transcript levels were measured in
negative control and SRF siRNA-transfected cells 4 h and 18 h
after they were mock- or parasite-infected. We found that relative
to negative control siRNA-transfected cells EGR1 and EGR2
induction was reduced in SRF siRNA-transfected cells by .80%
4 hpi and .90% 18 hpi (Figure 2B). These data indicate that SRF
is important for upregulating immediate early host gene expression
in Toxoplasma-infected cells and are consistent with our earlier data
showing that de novo protein synthesis was not required for
upregulation of EGR2 mRNA 6 hpi [24].
It is possible that a reduction in EGR1and EGR2 expression inthe
SRF siRNA-transfected cells was a result of decreased parasite
growth. We therefore assessed parasite growth by infecting negative
control and SRF siRNA-transfected cells with ß-galactosidase
expressing parasites and enumerating the parasites 72 h later. The
data indicated that loss of SRF had no impact on parasite growth (not
shown).Similarly,lossofSRFdidnotaffecttheabilityforTypeIIPru
strain parasites to undergo bradyzoite differentiation in the presence
of the bradyzoite-inducing agent Compound 1 (not shown) [26].
SRF Activation is Dependent on Parasite Secretion
We previously demonstrated that Toxoplasma upregulation of
EGR1 and EGR2 was mediated by a parasite-derived factor that
needed to be delivered to the host cell cytoplasm [24]. We
therefore hypothesized that if SRF was regulated by such a
secreted factor then SRF would only be activated in infected, but
not uninfected, cells. To test this hypothesis, COS cells stably
transfected with human CD8 under control of SRF [19] were
infected with GFP-expressing parasites or treated with cytochala-
sin D as a positive control [19]. The cells were harvested 18 h
later, stained with anti-CD8, and analyzed by flow cytometry. As
expected, cytochalasin D upregulated CD8 expression levels
(Figure 3A). Similarly, CD8 expression was increased only on
the surface of parasite-infected cells.
To further demonstrate a requirement for parasite secretion in
activating SRF, we used 4-bromophenacyl bromide (4-BPB), which
is an irreversible inhibitor of rhoptry and most likely dense granule
secretion [27], which are two parasite organelles whose contents are
released into the host cytosol [28,29]. We therefore pretreated the
parasites or SRE-luc transfectedhost cells with 1 mM 4-BPB for 159.
After washing out the drug, the treated parasites or host cells were
incubatedwithuntreated SRE-luctransfectedhost cells or parasites,
respectively. The cells were lysed 18 h later and luciferase activity
was measured. While SRE-luc activity was unaffected in the 4-BPB-
treated host cells, SRE-luc activation was significantly reduced
when cells were infected with pre-treated parasites (Figure 3B).
Together with our previous data excluding parasite microneme-
and surface-localized factors from stimulatingEGR expression [24],
these data indicate that SRF activation is mediated by a parasite-
derived rhoptry- or dense granule-localized factor.
Toxoplasma Signals Exclusively Through the SRF/TCF
Pathway
SRF functions in concert with either MAL or the TCF
complex. To test whether parasite activation of SRF is MAL-
Figure 2. SRF is Important for EGR1 and EGR2 Induction in Parasite-Infected Cells. A). SRF mRNA abundance was measured at the
indicated time points after transfection with SRF or negative control siRNAs. B). HeLa cells were transfected with SRF or negative control siRNA and
infected 48 h later. RNA was collected 4 and 18 h later, converted to cDNA, and EGR1 or EGR2 transcript levels measured by real time PCR. Shown are
averages and standard deviations of three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0018335.g002
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activate MAL dependent transcription. Thus, SRE-luc transfect-
ed host cells were pretreated with a fusion protein in which the
catalytic domain of Clostridium difficile TcdB toxin, is cloned
downstream of the 255 amino-terminal residues of Bacillus
anthracis LF [25]. This domain facilitates LF entry when it is
incubated with B. anthracis PA, which is the cell binding
determinant of Anthrax Toxin [30]. TcdB inhibits MAL-
dependent SRF activity due to its glucosylation and inactivation
of Rho GTPases that cause f-actin disassembly [31,32,33].
Phalloidin staining showed actin cytoskeletal disorganization in
the toxin-treated cells confirming TcdB-LF fusion protein uptake
and activity (not shown). We next mock-infected, parasite-
infected, or serum-stimulated TcdB-LF-treated, SRE-luc-trans-
fected cells and then measured luciferase activity. As expected,
addition of TcdB significantly reduced SRF activation in serum-
stimulated cells (Figure 4A). In contrast, Toxoplasma infection
similarly increased SRE-luc activity in the absence or presence of
the toxin.
SM22a is a cardiac specific protein whose promoter is activated
by changes in actin cytoskeletal dynamics but not growth factor
signaling since it is responsive to myocardin (a MAL family
member) but not TCF [34]. To test whether Toxoplasma infection
can stimulate MAL/myocardin-dependent SRF activity, luciferase
activity was compared between host cells transfected with either
the SRE-luc or SM22a-luc reporters. In contrast to cytochalasin D
that stimulated luciferase activity of both reporters, parasite
infection only upregulated the SRE-luc reporter (Figure 4B).
These data indicate that in Toxoplasma-infected cells SRF
activation does not require MAL, which is consistent with previous
data showing that few actin-associated genes are upregulated by
infection [10,12].
Figure 3. Toxoplasma Activation of SRF is Dependent on Rhoptry Secretion. A.) SRE-CD8 COS cells were mock treated, infected with RH GFP,
or treated with 1 mM cytochalasin D. Cells were collected 18 h later and analyzed by flow cytometry after staining with anti-CD8 antibody. Shown are
representative results from three independent experiments. B.) SRE-luc-transfected MEFs were mock- infected or infected with untreated parasites
(24BPB) or parasites pretreated with 4-BPB (Toxo+4BPB). In addition, SRE-luc-transfected cells were pretreated with 4-BPB and then infected with
untreated parasites (Host+4BPB). Luciferase activity was measured 18 h later. Shown are the averages and standard deviations of three independent
experiments performed in triplicate.
doi:10.1371/journal.pone.0018335.g003
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Toxoplasma-Infected Cells
MAPK signaling pathways are activated in parasite infected cells
[35,36,37] and mediate TCF/SRF activation [16]. Thus, luciferase
activity was measured 8 and 18 hpi in parasite-infected, SRE-luc-
transfected cells that were pretreated with inhibitors ofp38 (SB203580),
ERK (U0126), and JNK (SP600125) MAPKs. All three inhibitors
reduced SRE-luc activity in parasite-infected cells with p38 MAPK
inhibition having the most significant effect at 8 hpi (Figure 5A).
The importance for p38 MAPK signaling in SRF activation in
Toxoplasma-infected cells was assessed by co-transfecting the SRE-
luc cells with either an empty plasmid or a plasmid encoding a
dominant negative p38 MAPK mutant. Consistent with the
pharmacological data, expression of dominant negative p38
MAPK significantly reduced SRE-luc expression by ,60% in
parasite-infected cells (Figure 5B).
We next tested the hypothesis that activation of all three major
MAPK signaling modules was necessary for SRF activation in
Toxoplasma-infected cells. First, SRE-luc activity was measured in
Toxoplasma-infected host cells pretreated with a mixture of the
three inhibitors. We found that SRE-luc activation was reduced
.90% when host cells were treated with all three inhibitors
(Figure 5A ‘‘Toxo+Mix’’). Because pharmacological inhibitors can
have unintended effects on the parasite as well as the host cell, host
MAPK signaling was specifically inhibited with full length LF,
whose catalytic domain is a metalloprotease that cleaves the MAP
kinase kinases (MEKs), which are the direct upstream regulators of
p38, ERK, and JNK MAPKs [38,39,40]. SRE-luc transfected cells
were pretreated with LF and PA for 6 h, which was the minimal
time needed to reduce host MEK2 to below detectable levels (not
shown). The cells were then mock-infected, parasite-infected, or
treated with EGF, which activates SRF in a MAPK-dependent
fashion [18]. LF treatment reduced both EGF- and parasite-
stimulated increases in SRE-luc activity (Figure 5C). This effect
was not a consequence of using a bacterially expressed
recombinant protein since the LF-TcdB fusion protein, which
was similarly expressed in and purified from E. coli, had no effect
on parasite activation of the SRE-luc (Figure 4A). Together, these
data indicate that Toxoplasma activation of SRF/TCF is dependent
on collective ERK, JNK, and p38 MAPK signaling.
Discussion
Once a host cell comes in contact with Toxoplasma,n u m e r o u s
events take place including changes in host cell transcription [41,42].
This is accomplished, in part, by activation of transcription factors
such as HIF-1, STAT3/6, NF-kB, AP-1, and EGR. It is becoming
increasing clear that Toxoplasma regulates these transcription factors
by distinct mechanisms. Asexamples,HIF-1 activation is achieved by
a soluble secreted factor that stimulates signaling through the Activin-
Like Receptor Kinases ALK4,5,7 [22]. Toxoplasmaregulates STAT3/
6o rN F - kB by injecting into the host cell cytoplasm rhoptry- or dense
granule-localized factors, respectively [43,44,45].
SRF activation was only detectable in parasite-infected cells and
was severely reduced by an inhibitor that selectively blocks secretion
of the rhoptries and most likely dense granules, but not micronemes
[27]. These data are consistent with our previous work showing that
upregulation of EGR2 mRNA and subsequent EGR transcription
factor activity was most likely due to a rhoptry-derived factor [24].
Basedonthesecollectivedata,we proposethat SRFisactivatedbya
rhoptry-derived factor although we cannot exclude the possibility of
a dense granule-localized factor. The identity of this factor is not
known but we believe that it is distinct from the polymorphic
rhoptry kinases, ROP16 and ROP18, since activation of SRF target
genes did not map to these factors [12]. Although GT1 upregulated
EGR2 mRNA and the EGR luciferase reporter more weakly than
the other two strains, its upregulation of SRE-luc was similar to Pru
strain parasites. The basis for these differences is unclear but most
likely suggests that the SRF-inducing factor is most likely not
polymorphic. This conclusion is supported by microarray compar-
isons of strain-dependent differences in host gene expression [12].
We also observed that SRE-luc was more strongly activated by type
I RH parasites than by GT1 type I parasites. Although the sequences
of these two strains are highly similar, differences do exist that
culminate in RH being able to survive extracellularly for longer
amounts of time [46], invades more rapidly (our unpublished results),
and has a significantly shorter doubling time [46]. The basis for these
phenotypes is unknown but gene expression differences between the
two strains are likely to be an underlying factor. As an example,
ROP38 is a rhoptry-derived kinase that is secreted into host cells and
down regulates the expression of several SRF target genes including
E G R 2 .W h i l eR O P 3 8i sa b u n d a n t l ye x p r e s s e db yG T 1 ,P r u ,a n d
CTG strains, its expression in RH is significantly lower [47]. Thus, we
propose a model in which parasite activation of host MAPK signaling
leads to SRF activation and that SRF activity will be sustained in
strains (e.g. RH) that express low ROP38 levels. However, it is also
Figure 4. Toxoplasma Does Not Signal Through MAL. A.) SRE-luc
transfected MEFs were incubated with TcdB-LF and PA for 6 hours. Cells
were washed and either treated with 15% FBS for 6 h or infected for
16 h at which time luciferase activity was measured. B.) MEFs
transfected with either SRE-luc (white bars) or pSM22a-luc (black bars)
were parasite-infected or treated with 1 mM cytochalasin D. Luciferase
was activity measured 16 h later. Shown are the averages and standard
deviations of three independent experiments performed in triplicate.
doi:10.1371/journal.pone.0018335.g004
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andthethree other strains and our future experimentswilladdressthis.
In some instances SRF activation is important for cell growth
and survival [48,49]. This feature led us to test whether SRF
activation was important for Toxoplasma replication within its host
cell and we found that parasite growth was not dependent on SRF.
In addition, we could not detect a role for SRF in bradyzoite
development after the parasites were treated with the bradyzoite-
inducing agent, Compound 1 [26]. Thus, under the conditions of
these in vitro assays SRF activation appears to be dispensable. But
whether SRF is important for parasite growth in other cell types
and/or growth conditions or if it has a role in virulence will be the
focus of future experiments.
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